Call Us: 1.800.873.5297


Risperdal: $2.5 Million Verdict for Plaintiff in Philadelphia State Court

Philadelphia Daily News reports that a Philadelphia jury has awarded a 20 year old autistic man, Austin Pledger, $2.5 million after he developed size 46 DD breasts (a condition referred to as gynecomastia) as a young teenager after using the antipsychotic drug Risperdal. In particular, the jury found that the manufacturer, Johnson & Johnson, failed to adequately warn of the potential side effects associated with the use of the drug.

The Food and Drug Administration (FDA) initially approved Risperdal in 1993 for adults with schitzophrenia. Risperdal was not approved for children or adolescents until later in 2006. Pledger began using Risperdal for the first time in 2002 at the age of eight because his mother sought something to help with his irritability associated with his autism. Pledger’s doctor testified to the jury that he was unaware of information contained in one of the clinical studies that suggested that one of the side effects associated with use of Risperdal was gynecomastia.

Although counsel for defendants stressed to the jury that the company’s label adequately conveyed the risks of Risperdal, one of the plaintiff’s expert witnesses disagreed. David Kessler, former FDA commissioner, testified that the manufacturers did not adequately warn of the risks of the drug despite the fact that one of its own studies demonstrated increased levels of the hormone prolactin, which can lead to gynecomastia. Kessler said, “If somebody is sending a sales rep into a doctor’s office, into a pediatric neurologist’s office, and doing it multiple times, you have an obligation to provide adequate direction. Tell the good. Tell the bad.”

Philadelphia Daily News reports that this was the first case that has went before a jury regarding Risperdal and the condition gynecomastia, but thousands more lawsuits are pending in other states across the nation.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future
cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits. The lawyers of Schlichter, Bogard, & Denton have won some of the most high-profile class action lawsuits in the country. Visit their website today for more information.

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.